Aurigene Oncology CEO On Biotech Valuations, CAR-Ts And Reimbursement Models

 
• By Anju Ghangurde
  
Dr Murali Ramachandra, CEO of Aurigene Oncology
Dr Murali Ramachandra, CEO, Aurigene Oncology (Aurigene)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Interviews

More from India